ACT-1 peptide

未知生产厂商

技术标识符

专利

每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。

Inhibition of TREM receptor signaling with peptide variants
US 8513185 B2申请人: SIGALOV ALEXANDER B优先权: 2010
US
7 件公开
GLP-1 receptor modulators
- US 8778923 B2
  申请人: RECEPTOS INC优先权: 2012
  CN
  US
  5 件公开
- US 9260427 B2
  申请人: RECEPTOS INC优先权: 2013
  CN
  US
  3 件公开
N-ACYL-HYDRAZONE COMPOUNDS, USE IN THE TREATMENT OF AMYLOID AND NON-AMYLOID DEGENERATIVE AGGREGOPATHIES, AND PHARMACEUTICAL COMPOSITION
EP 4122921 A4申请人: FACULDADES CATOLICAS优先权: 2020
EP
US
WO
4 件公开
Inhibition of TCR signaling with peptide variants
US 10138276 B2申请人: SIGALOV ALEXANDER B优先权: 2010
US
4 件公开
SOLUBLE RECOMBINANT HUMAN PODOPLANIN RECEPTOR
EP 4777128 A1申请人: SENTRIMED INC优先权: 2023
CN
EP
WO
3 件公开
DPP-4 INHIBITOR
US 2014309401 A1申请人: NIPPI INC优先权: 2011
CN
US
3 件公开
Conditional superagonist CTL ligands for the promotion of tumor-specific CTL responses
US 9314516 B2申请人: YEE CASSIAN优先权: 2011
US
3 件公开
Peptide dimers as agonists of the erythropoietin (EPO) receptor, and associated methods of synthesis and use
US 7459522 B2申请人: AFFYMAX INC优先权: 2003
US
2 件公开
OXYNTOMODULIN ANALOGS
US 2012165503 A1申请人: CARRINGTON PAUL E优先权: 2009
US
2 件公开
T20 constructs for anti-HIV (human immunodeficiency virus) therapy and/or vaccines
US 9687547 B2申请人: IMMUNOMEDICS INC优先权: 2016
US
2 件公开